Company intelligence / Profile preview

liberDi

Ownership: Private
Development stage: Commercial

Overview

liberDi has developed a portable, automated peritoneal dialysis system that enables anywhere/anytime home-based treatment for kidney failure patients. The system has received FDA clearance for the US market following successful clinical trials with Israel’s largest HMO. It aims to improve quality of life by reducing side effects and increasing independence compared to traditional treatments[1][2].

Therapeutic areas: Nephrology
Modalities: DeviceNon-pharmacological therapyDigital health solution
Industry: Therapeutic Medical Devices

Partnerships

Clalit Health Services (Israel’s largest HMO)[1]

Beyond the preview

Go deeper on liberDi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on liberDi.

Explore the full profile